Genetic mutations of Armc5 protein are associated with the occurrence of a rare type of Cushing syndrome.

‘Genetic mutations of the Armc5 protein disrupt fetal development and compromise the immune response. A better understanding of the mechanisms of action of ARMC5 could lead to new treatments for endocrine disorders.’

The results of this
study, which was recently published in Nature Communications,
shed light on the vital role this protein plays in fetal development
and in T-cell and adrenal gland biology. A better understanding of the
mechanisms of action of ARMC5 could lead to new treatments for endocrine
disorders. 




The study showed that this protein's RNA is highly expressed in the thymus and adrenal glands. Development of a new Armc5-deficient experimental model highlighted the essential role this protein plays in the early activation phase of T-cells, which contribute to the immune response. "The new experimental model will provide better insight into this protein's role in the immune response," said Professor Lamarre.
Further studies will be needed to learn more about the modes of action of ARMC5, whose function depends on the interaction with other proteins.
Source-Eurekalert